Stock data
PTC Therapeutics, Inc. (PTCT)
PTC Therapeutics, Inc. (PTCT) reported revenue of US$1.73B and net income of US$682.64M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$1.73B | — | US$866.93M | US$682.64M | — |
| 2024 | US$806.78M | — | -US$302.57M | -US$363.30M | — |
| 2023 | US$937.82M | — | -US$439.50M | -US$626.60M | — |
| 2022 | US$698.80M | — | -US$447.41M | -US$559.02M | — |
| 2021 | US$538.59M | — | -US$374.44M | -US$523.90M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$360.52M | US$83.50M | — |
| 2026-03-31 | US$272.55M | -US$2.81M | — |
| 2025-12-31 | US$164.68M | -US$134.97M | — |
| 2025-09-30 | US$211.01M | US$15.90M | — |
| 2025-06-30 | US$178.88M | -US$64.85M | — |
| 2025-03-31 | US$1.18B | US$866.56M | — |
| 2024-12-31 | US$213.17M | -US$65.89M | — |
| 2024-09-30 | US$196.79M | -US$106.65M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.